Nuvation Bio EPS NUVB

Diluted earnings per share by quarter and over the last twelve months, from 2020.

Nuvation Bio's earnings per share was −$0.44 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.18.

Earnings per share over time

Each fiscal year is the twelve months to its fourth quarter.

Quarter	Ended	EPS	On a year earlier	Last 12 months
Q2 FY26	Jun 30, 2026	−$0.18	n/a	−$0.44
Q1 FY26	Mar 31, 2026	$0.01	n/a	−$0.43
Q4 FY25	Dec 31, 2025	−$0.11	n/a	−$0.60
Q3 FY25	Sep 30, 2025	−$0.16	n/a	−$0.64
Q2 FY25	Jun 30, 2025	−$0.17	n/a	−$0.63
Q1 FY25	Mar 31, 2025	−$0.16	n/a	−$2.35
Q4 FY24	Dec 31, 2024	−$0.15	n/a	−$2.26
Q3 FY24	Sep 30, 2024	−$0.15	n/a	−$2.17
Q2 FY24	Jun 30, 2024	−$1.89	n/a	−$2.11
Q1 FY24	Mar 31, 2024	−$0.07	n/a	−$0.31
Q4 FY23	Dec 31, 2023	−$0.06	n/a	−$0.34
Q3 FY23	Sep 30, 2023	−$0.09	n/a	−$0.38

Companies in Drug Manufacturers - General nearest Nuvation Bio's size, closest first, today.

Company	EPS, 12 months	Growth
NUVBNuvation Bio	−$0.44
PAHCPhibro Animal Health	$2.44	+107% a year
ANIPANI Pharmaceuticals	$4.70
ANABAnaptysbio	$4.57
PCRXPacira BioSciences	$0.35
HRMYHarmony Biosciences	$3.09	−0% a year
OMEROmeros	$1.52
PBHPrestige Consumer Healthcare	$3.57	−16% a year
AMPHAmphastar Pharmaceuticals	$1.70	−36% a year
NRIXNurix Therapeutics	$2.31
ABUSArbutus Biopharma	$0.78
Peer median	$2.38